Ms. Erickson has served as Savara’s Chief Business Officer since August 2023. She is responsible for the company’s operational excellence, with the Project Management, Clinical Operations, Investor Relations, Corporate Affairs, and Advocacy Relations & Patient Engagement teams reporting to her. Since joining the company in October 2018, she has held roles of increasing responsibility (including SVP of Global Business Operations, Chief of Staff, Head of Investor Relations and Corporate Communications, and Interim Head of Quality Assurance). She is a seasoned biopharmaceutical executive with deep expertise across a number of disciplines. Previously, she held leadership roles within corporate, consulting, and agency settings at companies such as Mirati Therapeutics, Halozyme, Pfizer, and Ogilvy.